|
|
|
|
DOLUTEGRAVIR: ABSENCE OF DEVELOPMENTAL TOXICITY
INCLUDING NTDs IN ANIMAL STUDIES
|
|
|
Reported by Jules Levin
CROI 9th International Workshop on HIV and Women, Seattle, WA 02 Mar 2019
Romach EH1, Posobiec LM2, Laffan SB2, Solomon HM2, Ziejewski MK2, Stanislaus DJ2
1Viiv Healthcare, GlaxoSmithKline, RTP, NC; 2GlaxoSmithKline, Collegeville, PA
|
|
|
|
|
|
|